• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Inflammation inducing resistance for anti-cancer drug

Research Project

Project/Area Number 22791279
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Digestive surgery
Research InstitutionOsaka University

Principal Investigator

KOBAYASHI Shogo  大阪大学, 医学系・研究科, 助教 (30452436)

Project Period (FY) 2010 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2011: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2010: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Keywords胆道癌 / 化学療法抵抗性 / 胆道炎症 / アポトーシス
Research Abstract

Biliary tract cancer is commonly suffered from inflammation, such as cholangitis, obstructive jaundice, and liver abscess. In this study we evaluated the relationship between this inflammation and chemoresistance. The prognosis of the patients with possibility of cholangitis was poor and the surgical treatment to reduce cholangitis would have benefit for survival. IL-6 and TGF-βamong inflammation cytokines cross-talked in cholangiocarcinoma cells, and induced chemo-resistance for multi-anti cancer drugs. Induced Gemicitabine resistant cholangiocarcinoma cells produced IL-6 and TGF-βand inhibition of smad4 attenuate these chemo-resistance. These indicated that inflammation stimulated IL-6 and TGF-βproduction as cross-talk, which is one of the mechanisms of chemo-resistance for biliary tract cancer.

Report

(3 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report
  • Research Products

    (10 results)

All 2012 2011 2010

All Journal Article (4 results) (of which Peer Reviewed: 4 results) Presentation (6 results)

  • [Journal Article] Treatment of borderline cases for curative resection of biliary tract cancer2011

    • Author(s)
      Kobayashi S, Nagano H, Marubashi S, Wada H, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M
    • Journal Title

      J Surg Oncol

      Volume: 104巻 Pages: 499-503

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Hiroaki Nagano Comparison of 4-weekly vs. 3-weekly gemcitabine as adjuvant chemotherapy following curative resection for biliary tract cancer : A prospective randomized controlled trial2011

    • Author(s)
      Shogo Kobayashi, Atsushi Miyamoto, Junzo Shimizu, Masaki Kashiwazaki, Yutaka Takeda, Shigeyuki Ueshima, Yongkook Kim, Toru Kitagawa, Keizo Dono, Masaki Mori, Yuichiro Doki
    • Journal Title

      Journal of Cancer Therapy

      Volume: 2巻 Pages: 703-709

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Treatment of borderline cases for curative resection of biliary tract cancer2011

    • Author(s)
      Shogo Kobayashi
    • Journal Title

      Journal of Surgical Oncology

      Volume: 104 Issue: 5 Pages: 499-503

    • DOI

      10.1002/jso.21971

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Comparison of 4-weekly vs.3-weekly gemcitabine as adjuvant chemotherapy following curative resection for biliary tract cancer : A prospective randomized controlled trial2011

    • Author(s)
      Shogo Kobayashi
    • Journal Title

      Journal of Cancer Therapy

      Volume: 2 Issue: 05 Pages: 703-709

    • DOI

      10.4236/jct.2011.25095

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Presentation] 進行胆道癌の長期生存例の臨床病理学的特徴とその術前予測2012

    • Author(s)
      小林省吾、永野浩昭、和田浩志、川本弘一、丸橋繁、江口英利、種村匡弘、梅下浩司、土岐祐一郎、森正樹
    • Organizer
      日本外科学会
    • Place of Presentation
      千葉
    • Year and Date
      2012-04-14
    • Related Report
      2011 Final Research Report
  • [Presentation] 胆道癌におけるIL-6/ TGF-クロストークと化学療法耐性への影響2012

    • Author(s)
      山田大作、小林省吾、和田浩志、川本弘一、丸橋繁、江口英利、梅下浩司*、永野浩昭、土岐祐一郎、森正樹
    • Organizer
      日本外科学会
    • Place of Presentation
      千葉
    • Year and Date
      2012-04-13
    • Related Report
      2011 Final Research Report
  • [Presentation] A prospective randomized controlled trial comparing 4-weekly versus 3-weekly adjuvant chemotherapy with gemcitabine after curative resection of biliary tract cancer2012

    • Author(s)
      Shin Nakahira, Shogo Kobayashi, Atsushi Miyamoto, Junzo Shimizu, Masaki Kashiwazaki, Shigeyuki Ueshima, Yongkook Kim, Toru Kitagawa, Keizo Dono, Masaki Mori, Yuichiro Doki and Hiroaki Nagano
    • Organizer
      ASCO-GI
    • Place of Presentation
      USA, Friday
    • Year and Date
      2012-01-20
    • Related Report
      2011 Final Research Report
  • [Presentation] ゲムシタビン時代における非治療切除の意義2011

    • Author(s)
      小林省吾、丸橋繁、和田浩志、江口英利、種村匡弘、梅下浩司*、土岐祐一郎、森正樹、永野浩昭
    • Organizer
      日本胆道学会
    • Place of Presentation
      宮崎
    • Year and Date
      2011-09-16
    • Related Report
      2011 Annual Research Report 2011 Final Research Report
  • [Presentation] 胆道癌治癒切除例に対するゲムシタビン術後補助化学療法の投与法別無作為化比較試験結果2011

    • Author(s)
      清水潤三、小林省吾、堂野恵三、鳥正幸、金よう国、中平伸、武田裕、柏崎正樹、宮本敦史、永野浩昭、土岐祐一郎、森正樹
    • Organizer
      日本胆道学会
    • Place of Presentation
      宮崎
    • Year and Date
      2011-09-16
    • Related Report
      2011 Final Research Report
  • [Presentation] いわゆる' Borderline-Curative Resection'症例に対する胆道癌の治療法の検討2010

    • Author(s)
      小林省吾、永野浩昭、和田浩志、丸橋繁、江口英利、武田裕、種村匡弘、梅下浩司、土岐祐一郎、森正樹
    • Organizer
      日本肝胆膵外科学会
    • Place of Presentation
      仙台
    • Year and Date
      2010-05-27
    • Related Report
      2011 Final Research Report

URL: 

Published: 2010-08-23   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi